Perrigo Company plc Long-Term Debt, Maturity, Year Two
Perrigo Company plc (PRGO) had Long-Term Debt, Maturity, Year Two of $409.00 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2026-02-26
- 2025-12-31: Long-Term Debt, Maturity, Year Two $409.00M.
- 2024-12-31: Long-Term Debt, Maturity, Year Two $37.20M.
- 2023-12-31: Long-Term Debt, Maturity, Year Two $41.60M.
- 2022-12-31: Long-Term Debt, Maturity, Year Two $739.50M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2025-12-31 | $409.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $37.20M 10-K · filed 2025-02-28 |
| 2023-12-31 | $41.60M 10-K · filed 2024-02-27 |
| 2022-12-31 | $739.50M 10-K · filed 2023-02-28 |
| 2021-12-31 | $373.30M 10-K · filed 2022-03-01 |
| 2020-12-31 | $604.20M 10-K · filed 2021-03-01 |
| 2019-12-31 | $594.20M 10-K · filed 2020-02-27 |
| 2018-12-31 | $302.20M 10-K · filed 2019-02-27 |
| 2017-12-31 | $504.70M 10-K · filed 2018-03-01 |
| 2016-12-31 | $666.40M 10-K · filed 2017-05-22 |
| 2015-12-31 | $576.60M 10-KT · filed 2016-02-25 |
| 2015-06-27 | $758.50M 10-K · filed 2015-08-13 |
| 2014-06-28 | $443.40M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |